Cancer of Prostate Clinical Trial
Official title:
RIDERS: Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention: a Prospective Multicenter Randomized Controlled Trial
This is a prospective randomized multicenter study aimed at comparing 3D AI-AR-RARP vs. no 3D, verifying the impact of this new technology on oncological and functional outcomes after the procedure.
Considering that prostate cancer lesions are not identifiable during surgery, except in the case of extensive and advanced tumors, the surgeon does not have a real-time perception of the location of the tumor. The absence of clear spatial visualization can therefore lead to a positive surgical margin, particularly in tumors in the T3 stage (invasion of the prostatic capsule or seminal vesicles). Our hypothesis is that with the help of AI 3D AR during surgery, positive surgical margins can be avoided, or at least reduced, while preserving the neurovascular bundles, with a consequent improvement not only in postoperative functional outcomes (continence and potency), but also oncological ones (less biochemical disease recovery (BCR), less need for salvage radiotherapy, lower risk of metastasis). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05191017 -
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
|
Phase 1/Phase 2 | |
| Completed |
NCT00970203 -
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
|
Phase 2 | |
| Completed |
NCT03031418 -
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
|
||
| Completed |
NCT01639859 -
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci
|
N/A | |
| Not yet recruiting |
NCT06406803 -
The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients
|
N/A | |
| Completed |
NCT02362464 -
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
|
Phase 2 | |
| Enrolling by invitation |
NCT05844761 -
Real-time Motion Management During Prostate and Lung Radiotherapy
|
N/A | |
| Completed |
NCT03442075 -
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
|
||
| Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
| Completed |
NCT03444532 -
Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia
|
N/A | |
| Recruiting |
NCT05600400 -
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer
|
N/A | |
| Recruiting |
NCT04887935 -
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer
|
Phase 1 | |
| Completed |
NCT02235142 -
Prostatic Cancer Versus Androgen Deficiency
|
N/A | |
| Completed |
NCT01477749 -
Sipuleucel-T Manufacturing Demonstration Study
|
Phase 2 | |
| Active, not recruiting |
NCT03632980 -
Dynamic Focusing Evaluation for Prostate Cancer Treatment
|
N/A | |
| Recruiting |
NCT04319783 -
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
|
Phase 2 | |
| Recruiting |
NCT04258813 -
Onco-primary Care Networking to Support TEAM-based Care
|
N/A | |
| Recruiting |
NCT05361798 -
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy
|
Phase 2 | |
| Completed |
NCT04304196 -
Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme
|
N/A |